Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

It’s Here: Merck’s Keytruda Cleared For First-Line Lung Cancer

Oct 25 2016

• By Mary Jo Laffler

Related Content

Merck Poised To Be First To Market With A PD-1 For First-Line Lung Cancer

Jun 16 2016

'Total Disaster' In First-Line Lung Cancer For BMS's Opdivo

Oct 10 2016

Merck's Keytruda Chemo-Combo Data Has Big Implications For Future Of Immuno-Oncology

Oct 10 2016

Genentech’s Tecentriq Stakes New Claim With FDA Lung Cancer Approval

Oct 19 2016

Related Companies

Bristol Myers Squibb Company

Roche Holding AG

Additional Topics

Approvals Clinical Trials Commercial ImmunoOncology Cancer BioPharmaceutical

More from New Products

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window